Laguna-Torres V A, Pérez-Bao J, Chauca G, Sovero M, Blichtein D, Chunga A, Flores W, Retamal A, Mendoza S, Cruz M, Monge Z, Lavalle M, Gutiérrez J, Málaga J, Soto E, Loayza N, Bolívar D, Reyna R, Mendoza C, Oré M, González J, Suárez M, Montano S M, Sánchez J L, Sateren W, Bautista C T, Olson J G, Xueref S
Naval Medical Research Center Detachment, Lima, Peru.
J Clin Virol. 2005 Dec;34 Suppl 2:S61-8. doi: 10.1016/s1386-6532(05)80036-8.
Transfusion-transmitted infections (TTIs) constitute a major health problem worldwide where routine screening of blood or blood products is improperly done, and where non-medical injecting medications and/or drug use are prevalent. Prevalence and risk factors vary by geographic location and by the specific TTI (including HIV-1, HBV, HCV and HTLV-I).
To determine the prevalence and risk factors associated with TTIs among a sample of multi-transfused adult patients in Peru.
A cross-sectional multi-center study was conducted across seven major hospitals in Peru from February 2003 to September 2004. Self-reported behavior information (medical procedures, number of sexual partners, and drug use history) was analyzed, along with a review of exposure history from hospital medical records. Prevalences were calculated by TTI for different exposures, along with unadjusted and adjusted odds ratios for infection risk.
Overall, 192 (54.7%) of 351 multi-transfused patients were found infected with one or more TTIs. Number of transfusion units, years of transfusion history (6 or more), and number of treatment facilities (2 or more) were associated with HCV infection. Hemodialysis history was a common risk factor associated with HBV, HCV and HTLV-I infection. HIV infection was associated only with total number of transfusion units received.
High prevalences of HBV and HCV infection were found among Peruvian multi-transfused patients and were associated with a past history and number of blood transfusions, as well as with past hemodialysis procedures. TTIs continue to represent a significant public health problem in Peru. Continued vigilant attention to blood safety procedures, including universal screening and health care provider education, is recommended.
在全球范围内,输血传播感染(TTIs)是一个重大的健康问题,在那些血液或血液制品常规筛查执行不当、非医疗性注射用药和/或吸毒盛行的地区尤其如此。其流行率和风险因素因地理位置和特定的输血传播感染类型(包括HIV-1、HBV、HCV和HTLV-I)而异。
确定秘鲁多次输血的成年患者样本中与输血传播感染相关的流行率和风险因素。
2003年2月至2004年9月在秘鲁的七家主要医院进行了一项横断面多中心研究。分析了自我报告的行为信息(医疗程序、性伴侣数量和吸毒史),并查阅了医院病历中的暴露史。计算了不同暴露情况下各种输血传播感染的流行率,以及感染风险的未调整和调整后的优势比。
总体而言,351名多次输血患者中有192名(54.7%)被发现感染了一种或多种输血传播感染。输血单位数量、输血史年限(6年或更长)和治疗机构数量(2个或更多)与HCV感染有关。血液透析史是与HBV、HCV和HTLV-I感染相关的常见风险因素。HIV感染仅与接受输血的总数有关。
在秘鲁多次输血的患者中发现HBV和HCV感染的高流行率,这与既往输血史和输血次数以及既往血液透析程序有关。输血传播感染在秘鲁仍然是一个重大的公共卫生问题。建议持续密切关注血液安全程序,包括普遍筛查和对医疗保健提供者的教育。